Intragastric Balloons Market Size Poised To Reach USD 100.2 Million By 2028

 San Francisco, 3 May 2021: The Report Intragastric Balloons Market Size, Share & Trends Analysis Report By Balloon Type (Single, Dual), By Filling Material (Saline Filled, Gas Filled), By End Use, By Administration, By Region, And Segment Forecasts, 2021 - 2028

The global intragastric balloons market size is expected to reach USD 100.2 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 11.9% from 2021 to 2028. The rise in obesity and increasing demand for minimally invasive procedures are anticipated to be key market drivers.

Intragastric balloons are one of the most widely adopted endoscopic bariatric therapy devices in clinical settings. This can be attributed to complications associated with surgical weight loss treatments and the low eligibility criteria for surgical options leading to a rise in demand for effective minimally invasive weight-loss treatment options.

The safety concerns associated with the inflatable medical device are anticipated to make the pre-market and post-market scrutiny process of these devices by the regulatory authorities more stringent. For instance, in 2019, Apollo Endosurgery Inc., revised the labeling of its Orbera Intragastric Balloon System to include contradiction clarifications, precautions related to anticholinergic and psychotropic medications, and updated U.S. adverse event tables after it received an FDA safety letter.

Nonetheless, the extensive research activities related development of innovative and novel systems and up-gradation of existing intragastric balloons to overcome the shortcomings of the traditional inflatable medical devices are anticipated to facilitate market growth.

Access Research Report of Intragastric Balloons Market @ https://www.grandviewresearch.com/industry-analysis/intragastric-balloon-market

Intragastric Balloons Market Report Highlights

• According to The American Society for Metabolic and Bariatric Surgery (ASMBS) data, nearly 5,000 intragastric balloon implantations have been conducted since their U.S. FDA approval
• The single segment held the largest revenue share of the market in 2020 while the triple segment is expected to grow at a fast pace
• The gas-filled segment is anticipated to witness lucrative growth over the forecast period
• The hospital segment held significant revenue share in 2020 while the ambulatory surgical centers segment is expected to grow at a rapid pace
• The endoscopy segment dominated the market in 2020 and the pill form segment is expected to witness lucrative growth over the forecast period
• North America dominated the market in 2020 due to the presence of a large obese population and high adoption of bariatric procedures. In Asia Pacific, the market is expected to witness remunerative growth over the forecast period
• As of January 2019, Apollo Endosurgery has discontinued the sales and distribution of its ReShape Balloon

List of Key Players of Intragastric Balloons Market

• Apollo Endosurgery, Inc.
• Obalon Therapeutics, Inc.
• Allurion Technologies, Inc.
• Spatz3
• Helioscopie
• Endalis
• MEDSIL
• ReShape Medical, Inc.
• Lexel Medical

Access Press Release of Intragastric Balloons Market @ https://www.grandviewresearch.com/press-release/global-intragastric-balloon-market